These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4631325)

  • 21. Studies on the effect of tolbutamide, glibenclamide, HB 699, and glucose on serum insulin and blood glucose in gastro-enterectomized dogs.
    Bickel M; Geisen K; Schleyerbach R
    Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):118-38. PubMed ID: 101159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Secretion of insulin under the influence of sulfonylurea derivates (SH)].
    Rothenbuchner G; Raptis S; Pfeiffer EF
    Wien Z Inn Med; 1973; 54(2):69-77. PubMed ID: 4203274
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride, and glisoxepide. II. Repeated administration in combination with glucose.
    Haupt E; Köberich W; Beyer J; Schöffling K
    Diabetologia; 1971 Dec; 7(6):455-60. PubMed ID: 5004179
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of hypoglycemic sulfonamides on glucagon and insulin secretion in ducks and dogs.
    Kajinuma H; Kuzuya TT; Ide T
    Diabetes; 1974 May; 23(5):412-7. PubMed ID: 4208464
    [No Abstract]   [Full Text] [Related]  

  • 25. [Action of the sulfonylureas tolbutamide and glypentide on the lacticdehydrogenase plasma levels (author's transl)].
    García-Rafanell J; Morell-Mestre J
    Rev Esp Fisiol; 1974 Jun; 30(2):91-6. PubMed ID: 4421448
    [No Abstract]   [Full Text] [Related]  

  • 26. [The pharmacology of glisoxepide, a new oral antidiabetic].
    Puls W; Losert W; Loge O; Schillinger E; Keup U; Kroneberg G
    Arzneimittelforschung; 1974 Mar; 24(0):375-92. PubMed ID: 4408136
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical comparison between glipentide (Staticum) and glibenclamide in diabetics.
    Moncada Lorenzo E; Garcia RV; Barberia Layana JJ; Morant Ciscard JA; Calleja Canelas A
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):50-7. PubMed ID: 401712
    [No Abstract]   [Full Text] [Related]  

  • 28. Special pharmacology of the new sulfonylurea glimepiride.
    Geisen K
    Arzneimittelforschung; 1988 Aug; 38(8):1120-30. PubMed ID: 2904269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulinotrophic drugs. Effect on intestinal abosorption of sugar.
    Botros M; Selim R; Ghoneim K; Ghareeb A; Wahba N
    Diabetes; 1974 Feb; 23(2):112-6. PubMed ID: 4204422
    [No Abstract]   [Full Text] [Related]  

  • 30. [Current pathophysiological and clinical aspects of the mode of action of blood glucose lowering sulfonamides].
    Pfeiffer EF
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():477-502. PubMed ID: 4906024
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparative use of gliquidone and tolbutamide administered intravenously].
    Zilker T; Lüders L; Bottermann P
    MMW Munch Med Wochenschr; 1975 Sep; 117(36):1421-2. PubMed ID: 126376
    [No Abstract]   [Full Text] [Related]  

  • 32. [Behavior of serum insulin under the influence of glisoxepide with and without butylbiguanide].
    Birk W; Petrides P
    Arzneimittelforschung; 1974 Mar; 24(0):425-9. PubMed ID: 4408033
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experimental studies on the mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 2. Modification of blood sugar and thrombocyte aggregation by oral antidiabetics].
    Losert W; Hoder A; Scholz C
    Arzneimittelforschung; 1975 Feb; 25(2):170-9. PubMed ID: 804311
    [No Abstract]   [Full Text] [Related]  

  • 34. Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?
    Marble A
    Drugs; 1971; 1(2):109-15. PubMed ID: 4999930
    [No Abstract]   [Full Text] [Related]  

  • 35. [ADH-like mechanism of action of chlorpropamide in diabetes insipidus (a comparison with the antidiuretic effect of other blood glucose decreasing sulfonamides and hydrochlorothiazide)].
    Wigger W; Scheler F; Creutzfeldt W
    Klin Wochenschr; 1970 Jul; 48(14):855-61. PubMed ID: 5001116
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects.
    Haupt E; Köberich W; Beyer J; Schöffling K
    Diabetologia; 1971 Dec; 7(6):449-54. PubMed ID: 5004178
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of glimepiride and glibenclamide on insulin and glucagon secretion by the perfused rat pancreas.
    Ledercq-Meyer V; Akkan AG; Marchand J; Malaisse WJ
    Biochem Pharmacol; 1991 Sep; 42(8):1634-7. PubMed ID: 1930290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistological demonstration of insulin in islets of langerhans after stimulation of insulin secretion by glucose, sulphonylureas and insulin antibodies.
    Bürkle PA; Hemm G; Huber V; Federlin K
    Diabetologia; 1971 Dec; 7(6):423-30. PubMed ID: 5004177
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of gliquidone and glibenclamide following oral administration].
    Ziler T; Waldthaler A; Ermler R; Bottermann P
    MMW Munch Med Wochenschr; 1975 Sep; 117(36):1423-4. PubMed ID: 809687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral substitutes for insulin: modern appraisal of their action and indications.
    Isr J Med Sci; 1972 Jun; 8(6):677-710. PubMed ID: 4626310
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.